Age and gender specific calculation of BMI based on parent reported height and weight of child. The measure uses CDC BMI-for-age guidelines in attributing overweight status (85th percentile up to 94th percentile) and obesity status (95th percentile and above).
Measures how many times per week child 6-17 years exercises vigorously (based on AAP and CDC recommendations)
Determines the perentage of children who live with a smoker and if that smoker smokes inside the child´s house
This measure ascertains the perceived safety of child´s school.
This measure ascertains the parents´ perceived safety of child´s community or neighborhood.
This is a composite measure used to assess the need and receipt of care coordination services for children who required care from at least two types of health care services which may require communication between health care providers, or with others involved in child´s care (e.g. school).
A composite measure designed to assess the family-centeredness of care delivery along several dimensions: whether doctor 1) partners with family in care, 2) listens to patient/parent carefully, 3) spends enough time with child, 4)is sensitive to family values/customs, 5) provides needed information, 6)whether family is able to access interpreter help, if needed.
Whether children with special health care needs (CSHCN) ages 12-17 have doctors who usually/always encourage increasing responsibility for self-care AND (when needed) have discussed transitioning to adult health care, changing health care needs, and how to maintain insurance coverage
The percentage of adults 18 years of age and older who self-report receiving an influenza vaccine within the measurement period. This measure is collected via the CAHPS 5.0H adults survey for Medicare, Medicaid, and commercial populations. It is reported as two separate rates stratified by age: 18-64 and 65 years of age and older.
Percentage of end stage renal disease (ESRD) patients aged 6 months and older receiving hemodialysis or peritoneal dialysis during the time from October 1 (or when the influenza vaccine became available) to March 31 who either received, were offered and declined, or were determined to have a medical contraindication to the influenza vaccine.